Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

The Supreme Court Agreed to Hear a Major Medication Abortion Case

The upcoming ruling could curtail access to what is most commonly referred to as the abortion pill.

Marie Claire · Dec 13, 2023

BREAKING: Supreme Court to Consider Fifth Circuit's Abortion Pill Decision

The Court granted two petitions for certiorari seeking review of a controversial lower court decision limiting federal approval of mifepristone.

Reason · Dec 13, 2023

US supreme court agrees to consider abortion pill access

Case will determine future of mifepristone in first major abortion issue to reach country’s highest court since it overturned Roe

The Guardian - US · Dec 13, 2023

From analysis to the latest developments in health,
read the most diverse news in one place.

Supreme Court to hear abortion pill case

The court's action sets up a collision between the Food and Drug Administration's 23-year study and supervision of mifepristone, and the circumstances under which it can be prescribed.

WEKU · Dec 13, 2023

The Supreme Court will rule on limits on a commonly used abortion medication

The Supreme Court has agreed to take up a dispute over a medication used in the most common method of abortion in the United States

The Independent UK · Dec 13, 2023

FDA Seeks Power for Eyedrops Recalls Amid Foreign Inspections Woes

U.S. health officials grapple with inadequate inspection of overseas eyedrop factories, leading to recalls of potentially dangerous products.

Safer eyedrops will require new FDA powers and resources, experts say

Repeated recalls of eyedrops are drawing new attention to the limited powers U.S. regulators have to oversee medical products made overseas

The Independent UK · Dec 13, 2023

Read news from The Economist, FT, and more,
with one subscription

Supreme Court to hear abortion pill case - Roll Call

The case is the first major Supreme Court abortion case since the landmark Dobbs v. Jackson Women’s Health Organization decision last year.

Roll Call · Dec 13, 2023

3 Solid Pharma Stocks for a Healthy Year-End Portfolio

The pharma industry is transforming due to the rapid adoption of AI and global healthcare spending, fostering innovation and patient care advancements. Therefore, fundamentally sound pharma stocks Eli Lilly (LLY), Wave Life Sciences (WVE) and Johnson & Johnson (JNJ) might be worth adding to boost your portfolio. Continue reading.

StockNews.com · Dec 12, 2023

3 Pharma Powerhouses to Boost Your Year-End Investments

Backed by an ever-growing need for chronic disease treatments, rapid investments in research and development, and widespread integration of technology, the pharmaceutical sector is anticipated to flourish. Thus, as we approach the end of 2023, three solid pharma stocks, GoodRx Holdings (GDRX), CytomX Therapeutics (CTMX), and Neurocrine Biosciences (NBIX), could…

StockNews.com · Dec 11, 2023

Up First briefing: Trump won't testify; FDA approves landmark gene-editing treatment

Donald Trump plans to skip testifying for a second time in the New York civil fraud trial. The FDA has approved the first-ever gene-editing treatment for a human disease.

WEKU · Dec 11, 2023

The Rwanda plan is failing – so watch as our cowardly government blames the civil service

Ministers are spending £290m of taxpayers’ money on a scheme that is yet to deliver. It’s our job as public servants to point out flaws in their plans, says Dave Penman, general secretary of the FDA union

The Guardian - UK · Dec 10, 2023

How to protect against emerging STIs

From gonorrhea and syphilis to newer ailments, these are the STDs that you need to be on the watch for

Salon · Dec 10, 2023

Google could make the Pixel 8 Pro's thermometer a practical health feature

Code found in the Fitbit app suggests that it might soon be able to work with the Pixel 8 Pro's built-in thermometer.

Android Central · Dec 10, 2023

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu · Dec 9, 2023

US approves two gene therapies for sickle cell disease

The U.S. Food and Drug Administration on Friday approved a pair of gene therapies for sickle cell disease, including the first treatment based on the breakthrough CRISPR gene editing technology.

LiveScience · Dec 8, 2023

1st gene therapies for sickle cell cleared by FDA, including CRISPR treatment

The FDA approved two new therapies for sickle-cell disease, including the world's first-ever approved CRISPR therapy.

LiveScience · Dec 8, 2023

Widely used epilepsy drugs tied to rare, deadly side effect, FDA warns

The announcement comes after the FDA became aware of more than 40 cases of "DRESS syndrome" linked to the seizure medications levetiracetam and clobazam.

WEKU · Dec 8, 2023

FDA approves first gene-editing treatment for human illness

The Food and Drug Administration approved two genetic treatments for sickle cell disease, including one that uses gene-editing. The approvals offer hope for patients and signal a new medical era.

Get all your
news in one place.

100's of premium titles.
One news app.

Bored Panda · Dec 8, 2023

“No Such Thing As Organic Honey”: 50 People Share Food Industry Secrets

Big money brings tough competition, and businesses can try all sorts of tactics to get an edge. The post “No Such Thing As Organic Honey”: 50 People Share Food Industry Secrets first appeared on Bored Panda.

The Independent UK · Dec 8, 2023

Lawmakers seek action against Elf Bar and other fruity e-cigarettes imported from China

House lawmakers are demanding information on federal efforts to stop the influx of kid-appealing electronic cigarettes from China

StockNews.com · Dec 8, 2023

3 Pharma Stocks Flashing 'Buy' Signals in December

The pharmaceutical industry is well-positioned for robust growth, driven by growing healthcare expenditure globally and the rapid adoption of digital technologies. Given the industry’s tailwinds, fundamentally strong pharma stocks, Collegium Pharmaceutical (COLL), Eton Pharmaceuticals (ETON), and GSK plc (GSK) could be ideal buys this month. Continue Reading….

The Independent UK · Dec 7, 2023

Two babies infected with rare bacteria sometimes found in powdered infant formula

A Kentucky child is dead and a Missouri infant has brain damage from the same kind of bacteria that sparked powdered formula recalls and shortages last year

StockNews.com · Dec 7, 2023

3 Rising Pharma Stocks to Consider Buying Now

The pharmaceutical sector is transforming due to the swift uptake of digital solutions and worldwide spending growth. Hence, fundamentally strong pharma stocks Supernus Pharmaceuticals (SUPN), Astellas Pharma (ALPMY), and Eli Lilly (LLY) might be solid buys now. Read more….

Reason · Dec 7, 2023

Will Abortion Issues Return to the Supreme Court?

The Court has been asked to intervene in cases involving abortion pills and criminal prosecution of abortion doctors.

LiveScience · Dec 7, 2023

Vaccine for superbugs? New shot shows promise in early tests

A new vaccine, so far tested only in mice, broadly activates the immune system against a wide array of bacteria and fungi.

1 … 181 182 183 184

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.